NASDAQ:KOOL

Cesca Therapeutics. Stock Insider Trading

$11.35
-0.0292 (-0.257%)
At Close: Jun 18, 2025

Cesca Therapeutics. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 12 359 629 and sold 1 469 791 KOOL shares in the last 100 trades.

Insider Power

(Last 100 transactions)
0
Buy 12 359 629 Shares
Sell 1 469 791 Shares

Historical Insider Trades

Date Type Action Person Amount
Dec 26, 2019 Common Stock Buy Xu Xiaochun 683 824
Dec 26, 2019 Warrants to Purchase Common Stock Buy Xu Xiaochun 352 942
Dec 26, 2019 Common Stock Sell Xu Xiaochun 683 824
Dec 26, 2019 Warrants to Purchase Common Stock Sell Xu Xiaochun 352 942
Dec 20, 2019 Participation Interest in Convertible Note Sell Xu Xiaochun 0
Sep 16, 2019 Stock Option Buy Joseph Thomis 3 400
Dec 14, 2018 Stock Option Buy Cauble Jeffery 160 000
Dec 14, 2018 Stock Option Buy Cauble Jeffery 160 000
Dec 14, 2018 Stock Option Buy Cauble Jeffery 40 000
Dec 14, 2018 Stock Option Buy Cauble Jeffery 40 000
Sep 04, 2018 Common Stock Sell Joseph Thomis 35 000
Aug 28, 2018 Common Stock Buy Joseph Thomis 35 000
Aug 28, 2018 Common Stock Buy Joseph Thomis 35 000
Jun 22, 2018 Stock Option Buy Xu James 13 500
Apr 16, 2018 Stock Options Sell Xu James 34 000
Apr 16, 2018 Stock Options Sell Medford Russell M 34 000
Apr 16, 2018 Stock Options Sell Joseph Thomis 34 000
Mar 09, 2018 Stock Options Buy Joseph Thomis 54 000
Mar 09, 2018 Stock Options Buy Xu James 54 000
Jul 01, 2017 Common Stock Buy Cauble Jeffery 9 320
Jul 01, 2017 Common Stock Sell Cauble Jeffery 4 080
May 10, 2017 Stock Options Buy Joseph Thomis 12 250
May 10, 2017 Stock Options Buy Xu James 13 500
Mar 10, 2017 Common Stock (Restricted) Buy Cauble Jeffery 0
Mar 10, 2017 Common Stock Buy Cauble Jeffery 0
Click to get the best stock tips daily for free!
ABOUT CESCA THERAPEUTICS INC.
Cesca Therapeutics.
Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine in the United States and internationally. The company develops and manufactures automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. Its products include SurgWerks system, a proprietary system comprised ...
GOLDEN STAR
Ticker Change Signal Date
CACC
$487.05
2.63% Jun 04
G
GTM
$9.57
2.09% Jun 02
TAC
$8.90
26.97% May 12
UAA
$5.84
8.39% May 09
HBM
$7.41
33.33% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE